Free tool
Healthcare stocks
We cover 34 companies in the Healthcare sector. The median market value in the group is $24.13M. Across the group, the median move over the past trading day is −0.20%. 6% of the 34 with a 200-day average trade above it. Price change over the past year runs from −96.0% to −7.5% across the middle 80 percent of the group, with a median of −75.9%.
Other lists in this group
Table
34 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| C1CO34.SA | Cencora, Inc. | $52.41B | Large cap | −12.17% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
| R1MD34.SA | ResMed Inc. | $27.33B | Large cap | −38.24% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | $15.65B | Large cap | +7.37% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| ACH | Accendra Health, Inc. | $93.82M | Micro cap | −75.05% |
| TENX | Tenax Therapeutics, Inc. | $79.34M | Micro cap | −64.19% |
| XTNT | Xtant Medical Holdings, Inc. | $45.03M | Micro cap | −47.38% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| BALM4.SA | Baumer S.A. | $29.30M | Micro cap | +22.57% |
| ABVC | ABVC BioPharma, Inc. | $18.95M | Micro cap | −76.14% |
| RADX | Radiopharm Theranostics Limited | $18.29M | Micro cap | −58.87% |
| DARE | Daré Bioscience, Inc. | $14.54M | Micro cap | −62.84% |
| PDSB | PDS Biotechnology Corporation | $12.49M | Micro cap | −82.56% |
| IRIX | IRIDEX Corporation | $12.31M | Micro cap | −45.58% |
| MBRX | Moleculin Biotech, Inc. | $11.69M | Micro cap | −96.05% |
| VNRX | VolitionRx Limited | $4.89M | Micro cap | −97.47% |
| CVKD | Cadrenal Therapeutics, Inc. | $4.80M | Micro cap | −88.87% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| APVO | Aptevo Therapeutics Inc. | $4.34M | Micro cap | −92.52% |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −5.52% |
| NOTV | Inotiv Inc | $2.79M | Micro cap | −99.37% |
| RNAZ | TransCode Therapeutics, Inc. | $2.48M | Micro cap | −76.72% |
| SLXN | Silexion Therapeutics Corp | $1.97M | Micro cap | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $1.95M | Micro cap | −95.78% |
| BBLG | Bone Biologics Corporation | $1.70M | Micro cap | −71.35% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.07M | Micro cap | −96.58% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.